Physician profile
Ann Glasman
NPI 1699883736
$787.00
in general payments reported to CMS, 2019-2025
16 companies · $87.89 in 2025
The $87.89 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $45.92 · 2021: $40.67 · 2023: $291 · 2024: $85.32 · 2025: $87.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $135.28 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $122.83 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $106.08 | 2019-2025 | Farxiga, Airsupra |
| Pfizer INC. | $100.78 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $80.80 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.04 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $43.41 | 2019-2020 | |
| Shield Therapeutics INC | $25.00 | 2023 | Accrufer |
| Glaxosmithkline, LLC. | $23.58 | 2019 | |
| Exact Sciences Corporation | $19.96 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $17.42 | 2024 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $16.17 | 2025 | Zoryve |
| Medtronic, INC. | $13.88 | 2023 | Inpen Smart Insulin Delivery System |
| Dynavax Technologies Corporation | $12.97 | 2019 | |
| Amarin Pharma, INC. | $12.42 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Glasman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.